Vaibhav Singh
Overview
Explore the profile of Vaibhav Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh V, Urunikulavan V, Bar A
Dalton Trans
. 2025 Feb;
54(11):4566-4576.
PMID: 39945431
An insight into the route from the fixation of CO gas into CO and the concomitant formation of a novel series of carbonato-bridged dinuclear lanthanide(III) complexes is presented. Efficient and...
2.
Patel V, Shirbhate E, Singh V, Parveen S, Veerasamy R, Tiwari A, et al.
Curr Top Med Chem
. 2025 Feb;
PMID: 39936438
Anti-angiogenic therapy represents a promising approach to cancer treatment by targeting the vascular support systems of tumors rather than the tumor cells themselves. Antiangiogenic agents face numerous obstacles that impede...
3.
Shirbhate E, Singh V, Kore R, Koch B, Veerasamy R, Tiwari A, et al.
Expert Rev Anticancer Ther
. 2025 Jan;
25(2):121-141.
PMID: 39873641
Introduction: The synergistic combination of histone deacetylase inhibitors and platinum-based medicines represents a promising therapeutic strategy to efficacy and overcome drug resistance in cancer therapy, necessitating a comprehensive understanding on...
4.
Wu J, Huang E, McMullen M, Singh V, Mrdjen M, Bellar A, et al.
Hepatol Commun
. 2024 Dec;
8(12.
PMID: 39621302
Background: Dichloroacetate (DCA), a pan-pyruvate dehydrogenase kinase inhibitor, ameliorates multiple pathological conditions and tissue injury and shows strong potential for clinical applications. Here, we investigated the preventive effects of DCA...
5.
Singh V, Shirbhate E, Kore R, Vishwakarma S, Parveen S, Veerasamy R, et al.
Mini Rev Med Chem
. 2024 Jul;
25(1):76-93.
PMID: 38982701
Globally, one of the most prevalent cancers is colorectal cancer (CRC). Chemotherapy and surgery are two common conventional CRC therapies that are frequently ineffective and have serious adverse effects. Thus,...
6.
Kumar Kore R, Shirbhate E, Singh V, Mishra A, Veerasamy R, Rajak H
Cancer Invest
. 2024 Jul;
42(7):627-642.
PMID: 38966000
Currently, cervical cancer (CC) is the fourth recorded widespread cancer among women globally. There are still many cases of metastatic or recurring disease discovered, despite the incidence and fatality rates...
7.
Afaque S, Verma V, Agrawal U, Chand S, Singh V, Singh A
Cureus
. 2024 Apr;
16(3):e57274.
PMID: 38686237
Introduction: Legg-Calve-Perthes disease (LCPD) is a disorder involving the hips in young children of preschool and school-going age groups, more common in 4-8 years. The insufficient blood supply to the...
8.
Singh V, Suresh L, Sutter J, Bar A
Dalton Trans
. 2024 Apr;
53(17):7436-7449.
PMID: 38592674
A novel series of one-dimensional coordination polymers (CPs) is achieved a facile one-pot synthesis strategy employing the nitrate salts of trivalent lanthanides, a pentadentate chelating ligand, and triphenylphosphine oxide at...
9.
Deshmukh R, Singh V, Harwansh R, Agrawal R, Garg A, Singh S, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543191
Prostate cancer is one of the most life-threatening disorders that occur in males. It has now become the third most common disease all over the world, and emerging cases and...
10.
Verma S, Singh V, Nagampalli V, Ponsky L, Li C, Chao H, et al.
Mol Carcinog
. 2024 Mar;
63(6):1051-1063.
PMID: 38482990
Men with prostate cancer are at increased risk of developing cognitive decline by the use of second-generation androgen signaling inhibitors. To date, reliable and sensitive biomarkers that could distinguish men...